CO32 | Major surgery in patients with severe hemophilia A without inhibitors receiving prophylaxis with fitusiran

Background and Aims: Fitusiran is an RNA interference therapy that lowers antithrombin (AT) levels, thereby restoring hemostatic balance in patients with hemophilia A or B, regardless of inhibitor status. However, clinical experience with perioperative management of major surgery in patients receiv...

Full description

Bibliographic Details

Published in:	Bleeding, Thrombosis and Vascular Biology
Format:	Article
Language:	English
Published:	PAGEPress Publications 2025-10-01
Subjects:	Congenital and acquired hemorrhagic diseases.
Online Access:	https://www.btvb.org/btvb/article/view/239